{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:07:15Z","timestamp":1783487235175,"version":"3.55.0"},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T00:00:00Z","timestamp":1132272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective and design\u2002<\/jats:bold> Genetic screening in multiple endocrine neoplasia type\u00a02 (MEN\u00a02) has led to specific management guidelines based on genotype\u2013phenotype analysis. However, there is controversy regarding the appropriate age for prophylactic thyroidectomy in families with mutations in codon\u00a0804 in exon\u00a014 of the <jats:italic>RET<\/jats:italic> proto\u2010oncogene, where medullary thyroid cancer (MTC) may not develop until adulthood. We prospectively studied two MEN\u00a02A families, one with the V804L and the other with the V804M <jats:italic>RET<\/jats:italic> mutation, to report our experience of genetic and biochemical screening and prophylactic thyroidectomy. Family\u00a01 is one of the largest MEN\u00a02A families in the literature, where 22 prophylactic thyroidectomies have been performed.<\/jats:p><jats:p><jats:bold>Patients and results\u2002<\/jats:bold> C\u2010cell hyperplasia (CCH) was found in 23 out of 25 thyroidectomy specimens from family members of ages 5\u00a0years and upwards. MTC was found in 10 out of 18 adults of age 25\u00a0years upwards, including the family\u00a02 proband, who was found to have MTC with lymph node metastases at age 28. Phaeochromocytoma was only observed in one patient, but six cases of histologically confirmed hyperparathyroidism were seen in family\u00a01.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> We suggest that prophylactic thyroidectomy should not be delayed until adulthood in MEN\u00a02A families carrying codon\u00a0804 <jats:italic>RET<\/jats:italic> mutations, but should be performed when there is CCH, before the development of MTC, as close as possible to age 6\u00a0years, which is the age of the youngest reported case of MTC in \u2018804\u2019 families.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2005.02394.x","type":"journal-article","created":{"date-parts":[[2005,11,18]],"date-time":"2005-11-18T09:50:17Z","timestamp":1132307417000},"page":"636-641","source":"Crossref","is-referenced-by-count":54,"title":["Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with <i>RET<\/i> codon 804 mutations"],"prefix":"10.1111","volume":"63","author":[{"given":"Diana L.","family":"Learoyd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gosnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne S.","family":"Elston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia J.","family":"Saurine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Louise","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh W.","family":"Delbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Con Aglen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto\u2010oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng C.","year":"1996","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01423.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.8.7767"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.10.3740"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01903.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020152"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe038148"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00375.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.12.8070"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012915"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8403"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7640-9"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.138.4.409"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.3.1104"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2000.107103"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2000.11\/6\/111080"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.17.1587"},{"key":"e_1_2_5_19_2","first-page":"89","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Endocrine Organs","author":"Lloyd R.","year":"2004"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409293311302"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.681503.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2002.123006"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4718"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3 <557::AID-CNCR5>3.0.CO;2-6"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7608-9"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.111.2.e132"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2005.02394.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2005.02394.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:12:53Z","timestamp":1697227973000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2005.02394.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,18]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1365-2265.2005.02394.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02394.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,18]]}}}